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Abstract 
Ovine enzootic abortion (OEA) caused by the obligate intracellular bacterial pathogen Chlamydia abortus (C. abortus), 
is an endemic disease in most sheep‑rearing countries worldwide. Following infection, C. abortus establishes a com‑
plex host–pathogen interaction with a latent phase in non‑pregnant sheep followed by an active disease phase in the 
placenta during pregnancy leading to OEA. Improved knowledge of the host–pathogen interactions at these differ‑
ent phases of disease will accelerate the development of new diagnostic tests and vaccines to control OEA. Current 
evidence indicates that cellular immunity is essential for controlling C. abortus infection. We have previously described 
a model of mucosal (intranasal) infection of non‑pregnant sheep with C. abortus that replicates the latent and active 
phases of OEA. We have investigated antigen‑specific recall responses of peripheral blood mononuclear cells (PBMC) 
in sheep infected with C. abortus via the intranasal route to determine how these change during the latent and active 
phases of disease. By analysing cytokines associated with the major  CD4+ve  Thelper  (Th) cell subsets (Interferon‑gamma 
(IFN‑γ)/Th1; Interleukin (IL)‑4/Th2; IL‑17A/Th17; IL‑10/Tregulatory), we show that there is selective activation of PBMC 
producing IFN‑γ and/or IL‑10 during the latent phase following infection. These cytokines are also elevated during 
the active disease phase and while they are produced by sheep that are protected from OEA, they are also produced 
by sheep that abort, highlighting the difficulties in finding specific cellular immunological correlates of protection for 
complex intracellular pathogens.
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mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/publi cdoma in/
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Introduction
Chlamydia abortus (C. abortus) is a common infectious 
cause of ovine abortion world-wide (with the exception 
of Australia and New Zealand) despite the availability 
of commercial vaccines [1, 2]. The disease is variously 
referred to as ovine enzootic abortion (OEA), enzo-
otic abortion of ewes (EAE), ovine chlamydiosis and 
chlamydial abortion. A number of safety concerns, vac-
cination failure and transmission of disease to naïve 
animals have all been linked to the current commercial 
live-attenuated vaccines [3–6]. The lack of a serological 
DIVA (Differentiating Infected from Vaccinated Animals) 
test is a further complicating factor in the implementa-
tion of effective disease control strategies [7]. The devel-
opment of new control strategies incorporating a DIVA 
approach is hampered by a relatively poor understanding 
of how immune responses at different stages of infection 
relate to disease outcome.
Sheep become infected with C. abortus via the oro-
nasal route by contact with pasture contaminated with 
abortive placental membranes and fluids, aborted and 
pre-term foetuses or infected lambs that survive [1]. Pri-
mary infection of non-pregnant sheep can result in an 
asymptomatic, latent infection that leads to colonisation 
of placental trophoblast cells in the subsequent preg-
nancy, destruction of the chorionic epithelium and abor-
tions that manifest in the last 2–3 weeks of gestation [1, 
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8]. These events appear to be synchronised with the later 
stages of pregnancy as placental lesions have only been 
reliably observed from day 90 gestation onwards [9, 10].
The host immune responses during these different 
stages of infection and disease are not well understood. 
To investigate this we have experimentally reproduced 
a model of latent C. abortus infection in non-pregnant 
sheep which results in abortion in the subsequent preg-
nancy [11]. We have so far failed to identify a correlation 
between the humoral immune response, antigen-specific 
interferon-gamma (IFN-γ) production by peripheral 
blood mononuclear cells (PBMC) and disease outcome. 
Here, we expand the breadth and depth of our immu-
nological analyses of the cellular immune response fol-
lowing intranasal infection to include antigen-specific 
proliferation of PBMC and the concomitant expression 
of key cytokines that are associated with activation of the 
major  CD4+ve  Thelper  (Th) cell subsets (IFN-γ, interleukin 
(IL)-4, IL-10 and IL-17A) to gain a greater understand-
ing of latency and provide insight into protective immune 
mechanisms that could be exploited for the design and 
development of the next generation of safer, subunit vac-
cines to OEA.
Materials and methods
The experimental animal methodology has been 
described previously to include all clinical, histopatho-
logical and microbiological data along with some limited 
immunological analyses. Note that all data were pre-
sented by experimental inoculation group only, without 
reference to disease outcome [11]. An overview of the 
experimental design and timeline of sample points for 
the cellular immunology assays is shown in Figure 1.
Animal study ethical approval
This study was approved by the Moredun Animal Welfare 
Ethical Review Body (permit number: E37/07) and was 
compliant with the UK Animal (Scientific Procedures) 
Act 1986. All animals were monitored throughout the 
study for any clinical signs at least three times daily and 
all findings recorded. Any animal found to be suffering 
or requiring treatment was given appropriate veterinary 
care in accordance with standard veterinary practice.
Selection and assignment of experimental animals
As we have previously shown that there is considerable 
variation in both mitogen-driven and antigen-specific 
cellular responses in outbred sheep [12, 13], animals 
were pre-screened for baseline immune responses and 
then allocated to groups to avoid the introduction of bias 
between groups. On that basis, seventy-nine ewes were 
selected from a cohort of ninety-four Scottish Blackface 
sheep (3 to 5  years of age) seronegative for C. abortus 
(rOMP90 ELISA, [14]) by evaluation of cellular responses 
to C. abortus antigen and to the mitogen Concanavalin A 
(ConA; ICN Biochemicals, Cleveland, OH, USA) 2 weeks 
prior to challenge. As not all animals become pregnant, 
it was imperative to start with more sheep than required 
per group to ensure statistically robust numbers for the 
duration of the experiment.
Briefly, PBMC were subject to in  vitro lymphocyte 
stimulation assays using UV-killed C. abortus antigen, 
mock antigen (HEp-2 cell lysate), ConA as a positive 
control and culture medium as a negative control. Cul-
ture supernatants were analysed and quantified for the 
presence of IFN-γ by ELISA [13] and cellular prolifera-
tion was measured in duplicate cultures by 3H-Thymidine 
Experimental Timeline
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Figure 1 Experimental overview of cellular assays in relation 
to experimental inoculations with Chlamydia abortus and 
subsequent pregnancy. The experimental timeline of 36 weeks 
represented in the diagram with the timing of the cellular assays 
carefully selected to monitor responses pre‑inoculation to 
post‑parturition. Five time points were chosen for this, to correspond 
to pre‑inoculation (week 0), pre‑synchronisation and mating (week 
6), pre‑positive sub‑cutaneous (s/c) control (group 5) challenge to 
coincide with early pregnancy of the intranasal inoculation (i/n) 
groups (week 17), pre‑expected abortion period (week 22) and finally 
post‑abortion/lambing (week 36) where these are represented by 
grey arrows. The week of the study is anchored by the i/n at week 
0. For clarity, the pre‑inoculation bleed is referred to as occurring at 
week 0 and not week −2, consistent with the paper describing the 
experimental model [8]. The five cellular bleeds for the s/c positive 
control Group 5 are simultaneously referred to the following week 
numbers: −21, −11, 0, 5 and 19. The orange arrow represents the 
timing of i/n with Chlamydia abortus (C. abortus) of the sheep: Group 
1, 5 × 103 infection forming units (IFU)/mL, low dose; Group 2, 5 × 105 
IFU/mL, medium dose; Group 3, 5 × 107 IFU/mL, high dose group 
and group 4, sham inoculation group (no C. abortus). The blue arrow 
represents the subcutaneous inoculation at day 70 of gestation of 
group 5 with 2 × 106 IFU/mL over the left pre‑femoral lymph node. 
Red line represents the duration of pregnancy from week 12 to week 
33. The orange line represents when the abortions took place and 
the brown line the period of time when the lambing occurred in all 
groups.
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incorporation. Sheep were excluded on the basis of 
defined cut-off values to the recall chlamydial antigen 
and mitogen ConA, as outlined in Table 1. The animals 
were ranked according to responsiveness to ConA (IFN-γ 
production and cellular proliferation) and then randomly 
allocated across the five groups. Subsequently, twelve of 
these sheep did not become pregnant and were removed 
from the study, leaving a final cohort of sixty-seven.
Intranasal inoculation (Nasal‑associated Lymphoid Tissue 
challenge) of non‑pregnant sheep with Chlamydia abortus 
and sub‑cutaneous inoculation of pregnant sheep with C. 
abortus
Non-pregnant sheep were inoculated intranasally (i/n) 
over the pharyngeal mucous membrane using an adapted 
disposable syringe attached to a plastic tube with a per-
forated end cap to ensure even coating of the pharyngeal 
cavity, as previously described [11] with one of three 
doses of yolk-sac grown C. abortus: 5 × 103 (low dose; 
n = 16), 5 × 105 (medium dose; n = 18) and 5 × 107 (high 
dose; n = 19) inclusion forming units (IFU) (groups 1–3, 
21 animals each); an additional eight animals received an 
intranasal inoculation of yolk sac (sham control; group 4). 
Six sheep assigned to the positive control group were left 
untreated at this stage (group 5). All sheep were synchro-
nised for oestrus following application of progesterone 
sponges (Veramix, Upjohn Ltd, Crawley, UK) and then 
batch mated with rams, as previously described [11]. At 
70 days of gestation (dg) the group 5 sheep were inocu-
lated subcutaneously (s/c; group 5 will also be referred 
to as s/c control group) as previously described [11]. 
All animals were housed in separated groups to avoid 
cross-contamination. Rectal temperatures were recorded 
daily in groups 1–4 on the day of i/n and for a total of 
27 consecutive days. Abortions and lamb viability were 
monitored and samples were collected for pathologi-
cal, microbiological and immunological examination, as 
described previously [11].
Preparation of UV‑inactivated Chlamydia abortus antigen
The antigen used in the recall assays was UV-inactivated 
C. abortus strain S26/3 elementary body (EB) and reticu-
late body (RB) mixture [15]. The strain was propagated in 
HEp-2 cells using Iscove’s Modified Dulbecco’s Medium 
(IMDM) supplemented with 10% heat-inactivated (ΔH) 
fetal bovine serum (FBS, PAA Gold USA Origin, PAA 
Hanninger, Austria) and 2  mM  l-glutamine. Once con-
fluent, cells were infected with C. abortus strain S26/3 
inoculum for 4 h at 37 °C under 5%  CO2. The inoculum 
was then removed, replaced with IMDM 2% ΔH FBS and 
cultured for 72 h in a humidified incubator at 37 °C under 
5%  CO2. The asynchronous Chlamydia culture was har-
vested by mechanical disruption using sterile glass beads. 
The supernatant was clarified of cellular debris by centrif-
ugation at 900 × g for 10 min at 4 °C and transferred to 
small microfuge tubes for a final centrifugation step at 10 
000 × g for 10 min at 4 °C. The pelleted chlamydial EBs 
were resuspended in sucrose-phosphate-glutamate buffer 
(SPG) [16] and stored at -70  °C. The chlamydial antigen 
was UV-inactivated with 2000 rads using a Uvitec Cross-
Linker CL-E508.G 9 (Thermofisher, Cambridge, UK) and 
titrated in cellular assays with PBMC and assessed for an 
optimal IFN-γ concentration in culture supernatants, as 
described previously [11].
Blood collection and peripheral blood mononuclear cell 
(PBMC) preparation
Ten millilitres of venous blood was collected into vacu-
tainers on multiple occasions for the preparation of 
serum (Becton–Dickinson, Cambridge, UK) for the 
detection of humoral responses; twenty millilitres of 
additional blood were also collected into vacutainers 
containing lithium heparin (Becton–Dickinson) at five 
sample points designated as weeks 0, 6, 17, 22 and 36 in 
relation to i/n with C. abortus (Groups 1–3 and sham 
control Group 4) or weeks −21, −11, 0, 5 and 19 in rela-
tion to s/c inoculation with C. abortus (Group 5). PBMC 
were purified using a standard protocol [12], but without 
a separate buffy-coat preparation stage. Instead, whole 
blood was diluted 1:2 in PBS and layered directly onto 
the proprietary density gradient medium (Lymphoprep 
1.067 g/L, Axis Shield Diagnostics Ltd, Dundee, UK).
Lymphocyte stimulation assays
PBMCs were adjusted to 2 × 106 cells/mL in IMDM 
supplemented with 10% ΔH FBS, 2  mM  l-glutamine, 
gentamicin (50  µg/mL), 100  IU/mL penicillin, 50  μg/
mL streptomycin and 50  µM beta-mercaptoethanol 
Table 1 Cellular response cut-off values for animal 
selection 
For each lymphocyte stimulation assay in vitro treatment, defined cut-offs 
for animal selection were defined for IFN-γ production (measured on culture 
supernatant samples collected at 96 h as described in section “Cytokine ELISAs”) 
and for cellular proliferation (measured for the last 18 h of the 120 h culture 
as described in section “Cell proliferation assays”). For medium, HEp-2 and 
UV-Chlamydia abortus antigen the cut-off values for exclusion of outliers were 
above the values indicated in the IFN-γ production and cellular proliferation. 
For Concanavalin A, the cut-off values for exclusion of outliers were below the 
values indicated for IFN-γ and cellular proliferation, respectively.
Treatment IFN‑γ production 
cut‑off value (pg/
mL)
Cellular proliferation 
cut‑off value (counts 
per minute)
Medium Above 250 Above 30 000
HEp‑2 Above 250 Above 30 000
UV‑Chlamydia abortus Above 1100 Above 70 000
Concanavalin A Below 450 Below 150 000
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(Sigma-Aldrich, Dorset, UK). One hundred microliters 
of cell suspension was added to U-bottom tissue culture 
plates (Nunc, Thermofisher Scientific, Renfrew, UK). 
To the cells, 100  µL of previously titrated UV-killed C. 
abortus antigen, HEp-2 control lysate, ConA (5 μg/mL), 
or medium alone in quadruplicate wells for each treat-
ment. Duplicate assay plates were set up for collection 
of culture supernatant after 96 h of culture for cytokine 
analyses and 120  h of culture for cellular proliferation 
measurement.
Cell proliferation assays
PBMCs were labelled with [methyl-3H]-thymidine 
(0.5  μCi/well) (Amersham Biosciences UK Ltd, Lit-
tle Chalfont, Buckinghamshire, UK) for the last 18  h of 
a 120  h culture (as described in [12]). Cells were then 
harvested onto glass-fibre filters and radioactive signal 
measured using a 1450 MicroBeta TriLuxMicroplate 
Scintillation and Luminescence Counter (Perkin Elmer, 
Cambridge, UK). Data (treatment/animal) were collated 
and the counts per minute (cpm) values expressed as 
geometric means of quadruplicate wells.
Cytokine ELISAs
IFN-γ measurement has been described previously 
[11]. Those data were re-analysed in the context of the 
additional immunological parameters described here. 
Interleukin (IL)-4 and IL-10 were measured in an indi-
rect ELISA using antibody pairs (mAb clones CC313 
and CC314 for IL-4; CC318 and CC320 for IL-10, Bio-
Rad Antibody Laboratories, Oxford UK) and quanti-
fied using recombinant bovine (rbov) IL-4 of known 
concentration and recombinant ovine IL-10 of known 
biological activity [12, 17]. IL-17A was assayed and 
quantified using the bovine IL-17A ELISA kit (King-
fisher Biotech, Minneapolis, MN, USA) with rbov 
IL-17A standards, according to the manufacturer’s 
instructions; the kit cross-reactivity for ovine IL-17A 
has previously been reported [18].
Statistical analyses
The basic summary statistics were compiled for each 
immunological parameter and formal statistical com-
parisons were based on linear mixed models (LMMs) 
with identity link function and Gaussian errors fit-
ted by restricted maximum likelihood to rank-based 
inverse normal transformed data. Group, week and 
term accounting for the interaction between them were 
included as fixed-effect factors in the models, whereas 
animal ID was a random effect. Significance of the fixed 
effects was assessed by conditional F-tests. Post hoc pair-
wise comparisons between groups and weeks used t-tests 
based on estimated marginal means from the LMM fits, 
with the corresponding p-values being adjusted for multi-
plicity using the Benjamini and Hochberg’s method [19]. 
Separated LMMs were fitted including outcome of preg-
nancy (lambing or abortion) and potential interactions 
with the other factors as additional fixed effects to deter-
mine if there were specific associations with the immune 
responses measured for groups 1, 2 and challenge control 
group 5. However, this was not possible for the highest 
i/n dose group (group 3) due to only one abortion taking 
place. All the statistical analyses were performed on the 
R system for statistical computing v3 [20]. Significance 
tests were assessed at the usual 5% significance level.
Results
Baseline immunological responses for assignment 
of experimental animal groups
The animals were assigned in the study on the basis of the 
criteria documented for cellular proliferation and IFN-γ 
production shown in Table  1. PBMC were screened for 
recall responses to C. abortus antigen and for stimula-
tion with the T cell mitogen ConA to establish baselines 
assigned as week 0 prior to group allocation and inocu-
lation, as shown in Figures  2A–D. Responses of each 
animal are represented by a single bar, with red bars indi-
cating the animals excluded from the study based on a 
combination of the cut-off criteria listed in Table 1 (high 
background responses to antigen and/or low stimula-
tion with ConA). The retained animals were then ranked 
by the magnitude of their PBMC to produce IFN-γ in 
response to ConA. Animals of “low, medium and high 
IFN-γ production capacity” were then systematically 
assigned to each experimental group. Once assigned, 
statistical comparisons of the groups revealed no statisti-
cally significant differences in their cellular responses to 
ConA, as determined by IFN-γ production (p = 0.9916) 
or cellular proliferation (p = 0.8702). Equally, the baseline 
responses to C. abortus antigen were consistent across 
the groups for both IFN-γ production (p = 0.6062) and 
cellular proliferation (p = 0.8662). These data served as 
a solid basis for determining antigen-specific cellular 
responses between the groups following inoculation with 
C. abortus.
Summary of pregnancy outcomes
The five experimental groups gave rise to the following 
outcomes at parturition: group 1 (low dose) 6 lambed and 
10 abortions (59% abortion rate); group 2 (medium dose) 
6 lambed and 12 abortions (67% abortion rate); group 
3 (high dose) 18 lambed and 1 abortion (5% abortion 
rate); group 4 (sham control) 8 lambed; and group 5 (s/c 
control) 3 lambed and 3 abortions (50% abortion rate). 
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Abortions due to C. abortus were confirmed by micro-
biological assessments, as previously described [11].
Cell‑mediated immune responses
The PBMC responses to culture medium and the nega-
tive control antigen (HEp-2 cell lysate control) treatments 
served as set up controls for the cellular assays. The cel-
lular proliferation and cytokine production of PBMC 
cultured in these conditions were all low or undetectable 
and are therefore not shown.
Cellular proliferation to ConA
The cellular proliferation to ConA was broadly consist-
ent throughout the study for all the groups (p = 0.5364) 
with a geometric mean of 200 000 to 300 000 cpm (Addi-
tional files 1A–E). There is a significant effect of time 
(week p < 0.0001) with the proliferative response notion-
ally changing over time, statistically significant peak-
ing at week 6 (p < 0.0081). The lowest responses were 
observed at week 36 post i/n and week 19 s/c inoculation 
(p < 0.0333).
Figure 2 Cellular immune responses of sheep used for selection and assignment of experimental groups. Peripheral blood mononuclear 
cells from the 94 sheep were purified and set up in lymphocyte stimulation assays in vitro at week 0 with the mitogen Concanavalin A (ConA) and 
UV‑inactivated Chlamydia abortus (C. abortus) antigen (as described in full in section “Lymphocyte stimulation assays”) with duplicate plates set up 
for the measurement of cellular proliferation (as described in full in section “Cell proliferation assays”) and culture supernatants (collected at 96 h). In 
brief, cellular proliferation was measured for the last 18 h of the 120 h culture, 0.5 microCurie/well was added and plates were harvested and data 
collated for individual animals as the geometric mean of quadruplicate values. Interferon‑gamma (IFN‑γ) production was measured in the culture 
supernates by a specific quantifiable ELISA (as previously described [11]). The data are displayed in bar graphs with individual animal data shown 
as single bars. Black bars represent sheep retained for the study and red bars represent sheep removed from the study. A Cellular proliferation to 
ConA. Where the x axis displays data for individual animals and the y axis shows the cellular proliferation data presented in counts per minute units. 
B Cellular proliferation to C. abortus antigen, where the x axis displays data for individual animals and the y axis shows the cellular proliferation data 
presented in counts per minute units. C IFN‑γ production to ConA, where the x axis displays data for individual animals and the y axis the IFN‑γ 
production units in picograms/millilitre. D IFN‑γ production to C. abortus antigen, where the x axis displays data for individual animals and the y axis 
the IFN‑γ production units in picograms/millilitre. The statistics displayed on each graph have been derived from Linear Mixed Modelling (LMM) as 
described in detail in section “Statistical analyses”.
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IFN‑γ production to ConA
The capacity of PBMC to produce IFN-γ in response to 
ConA stimulation was also consistent between groups 
(p = 0.5778) with the magnitude of responses significantly 
lower at week 6 and 17 i/n (week -11 and week 0 for s/c 
group 5) compared to other weeks (p < 0.0292). There is a 
statistically significant effect of time (p < 0.0001) suggest-
ing variability of the IFN-γ response but no interaction 
between group and time effects (p = 0.1444; Additional 
files 2A–E).
IL‑4 production to ConA
The IL-4 production to ConA appears to gradually 
increase leading to week 22 i/n (p < 0.0001) but the pat-
terns are consistent across the groups (p = 0.5065; Addi-
tional files 3A–E). There is greater variability of response 
across time for the sham control group 4 and s/c control 
group 5 that may be contributing to the significant inter-
action between group and time (p = 0.0316) with appar-
ent evidence of divergent group responses over time.
IL‑10 production to ConA
The IL-10 response to ConA across time was variable 
(p < 0.0001) generally dropping in magnitude to week 36 
i/n. Groups 4 and 5 were particularly inconsistent and 
variable as shown by the large error bars (Additional files 
4D–E) and again this may be contributing to the signifi-
cant interaction between group and time (p = 0.0040).
IL‑17A production to ConA
There is no statistically significant difference in IL-17A 
production to ConA between the groups (p = 0.6450) 
over the duration of the study. IL-17A production to 
ConA across groups peaked around week 6 (p < 0.495) 
and gradually dropping thereafter to week 36 i/n 
(p < 0.0672). The pattern of responses in groups 4 and 
5 are less consistent over time contributing to the time 
effect (p < 0.0001; Additional files 5A–E). Groups 1–3 had 
similar patterns of responses over time and that contrib-
uted to the non-significant interaction effect (p = 0.0652).
In vitro recall responses to C. abortus antigen
Cellular proliferation to C. abortus antigen
The background responses to chlamydial antigens 
were generally below 50 000 cpm and equivalent across 
all groups at week 0 prior to oronasal inoculation 
(p = 0.9916; Figure  2B). Analysis of the cellular prolif-
eration to the chlamydial antigen by LMM reveals that 
responses significantly change over time across the 
groups (week, p < 0.0001, Figures  3A–E) for the entire 
study. This gives rise to clear patterns of responses to i/n 
group 1–3 and s/c infection group 5 (group p = 0.0417) 
when compared with the sham control group 4 (for all 
five cellular bleeds). The divergence of the responses 
between the groups over time gives a significant interac-
tion effect (week: group, p = 0.0014).
There are specific changes in the magnitude of the cel-
lular proliferation groups 1–3 vs group 4; and group 5 vs 
group 4 that coincide with post i/n and post s/c bleeds 
(week 6 i/n and week 22 i/n/week 0  s/c), respectively, 
when compared to the proceeding bleed (week 0 vs week 
6 i/n, p < 0.0001; and week 0 vs week 5  s/c, p < 0.0001). 
This is a direct change in the response to Chlamydia 
infection and is statistically significant across all five 
experimental groups. This shows clear trends of elevated 
proliferation to i/n groups 1–3 vs group 4 at week 6, 
(p < 0.1908) or s/c C. abortus infection week 5 for group 5 
vs group 4 (p = 0.0092).
At the pre-parturition bleed (i/n week 22 and s/c week 
5), the magnitude of the proliferative responses in groups 
1–3 plus 5 over the sham control group are highly statis-
tically significant (p < 0.0092). This clear response in the 
i/n and s/c groups at week 22 i/n and week 5 s/c drops at 
the week 36 i/n (or week 19 s/c) post-parturition bleed.
Cytokine production to C. abortus antigen
As stated earlier, animals were allocated to groups on the 
basis of PBMC proliferation and IFN-γ production. Anal-
yses of PBMC supernatants for IL-4, IL-10 and IL-17A 
also revealed no inter-group differences, consistent with 
the patterns observed for cellular proliferation and IFN-γ 
production at week 0 i/n (or week -21 s/c).
IFN‑γ production
There is a meaningful effect of time on the antigen-
driven IFN-γ response (week p < 0.0001), consistent with 
the cellular proliferation response. The i/n groups 1–3, 
s/c group 5 and sham control group 4 are significantly 
different (group p = 0.0031; Figures  4A–E) with these 
responses diverging over time (interaction effect week: 
group p = 0.0001).
The pattern of IFN-γ responses broadly follows 
that of the cellular proliferation with significant dif-
ferences between the i/n groups 1–3 vs sham control 
group 4 (p < 0.0373) and s/c control group 5 v group 
4 (p = 0.0267). The antigen-driven IFN-γ response 
increases following i/n from week 6 and peaks around 
week 22. There is variability in the magnitude of the 
responses between groups 1–3 over time but these differ-
ences are not consistent over time (p < 0.5147). The IFN-γ 
response significantly increases across the groups from 
week 17 to week 22 i/n and week 0 to week 5 s/c group 5 
(p < 0.0001) corresponding to mid-pregnancy to the pre-
abortion time period. All i/n groups 1–3 and s/c group 5 
have significant IFN-γ production compared to the sham 
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control group 4 (p < 0.0177). The IFN-γ response drops 
after parturition at week 36 but the level of responses are 
still elevated significantly over the sham control group 4 
(p < 0.0478).
IL‑4 production
The level of chlamydial antigen-driven IL-4 production 
was negligible across the five experimental groups and 
indistinguishable in magnitude from the HEp-2 negative 
control antigen (data not shown).
IL‑10 production
The magnitude of antigen-driven IL-10 responses were 
generally lower than responses simulated by ConA, How-
ever, there is a significant effect of week for chlamydial 
antigen-stimulated IL-10 production as determined 
by the LMM analyses (week, p < 0.0001). The IL-10 
responses across the groups are significantly different 
(group, p = 0.0001; Figures  5A–E) and these responses 
to antigen diverge over time (week: group p = 0.0414). 
Each i/n group and the s/c group 5 have significantly 
Figure 3 Cellular proliferation to C. abortus antigen. Peripheral blood mononuclear cells from the 67 sheep in the five experimental groups 
were purified from whole blood (as described in section “Lymphocyte stimulation assays”) on five occasions and set up in lymphocyte stimulation 
assays in vitro with the UV‑inactivated Chlamydia abortus (C. abortus) antigen (set up as described in section “Lymphocyte stimulation assays”). 
One set of the duplicate plates were analysed for cellular proliferation (described in full detail, section “Cell proliferation assays”). In brief, cellular 
proliferation was measured for the last 18 h of the 120 h culture, 0.5 microCurie/well was added and plates were harvested and data collated for 
individual animals as the geometric mean of quadruplicate values. The datasets from each experimental group is presented in individual line 
graphs. The data points are the arithmetic mean values for each cellular bleed and the error bars represent the standard error of the mean (SEM). 
The x axis represents the weeks post inoculation with C. abortus (intranasal inoculation (i/n) Groups 1–3 with i/n sham control Group 4; and 
sub‑cutaneous inoculation (s/c) Group 5). The week numbering for groups 1–4 are consistent in relation to i/n whereas group 5 is in relation to s/c. 
The y axis represents the arithmetic mean cellular proliferation in counts per minute. A Group 1 (low dose), B Group 2 (medium dose), C Group 3 
(high dose), D Group 4 (sham control) and E Group 5 (sub‑cutaneous control). The statistics summarised in the figure been derived from Linear 
Mixed Modelling (LMM) as described in detail in section “Statistical analyses”.
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different IL-10 responses when compared to the sham 
group 4 (p < 0.0032). There is a consistent significant 
increase in antigen-driven IL-10 in the time point fol-
lowing i/n C. abortus infection for groups 1–3 (week 0 vs 
week 6, p < 0.0001) and s/c for group 5 (week 0 vs week 5, 
p = 0.0056). This IL-10 response remained elevated in the 
infected groups through to the pre-abortion i/n week 22 
and s/c week 5 over the sham control group 4.
IL‑17A production
The magnitude of IL-17A production following exposure to 
chlamydial antigens (Figures 6A–E) was much lower than 
those to ConA (Additional file 5), irrespective of the infec-
tion group. In contrast to the IFN-γ and IL-10 production 
there was no sustained IL-17A response to i/n or s/c C. 
abortus infection (week, p = 0.3597). There was a lot of var-
iability in the IL-17A response and any differences between 
groups were not sustained (group, p = 0.6467) nor did these 
responses concertedly diverge (week: group, p = 0.0644).
Figure 4 IFN‑γ production to C. abortus antigen. Peripheral blood mononuclear cells from the 67 sheep in the five experimental groups 
were purified from whole blood (as described in section “Blood collection and peripheral blood mononuclear cell (PBMC) preparation”) on five 
occasions and set up in lymphocyte stimulation assays in vitro with the UV‑inactivated Chlamydia abortus (C. abortus) antigen (set up as described 
in section “Lymphocyte stimulation assays”). One set of the duplicate plates were harvested for culture supernatants after 96 h and analysed for 
interferon‑gamma (IFN‑γ) production (as previously described [11]). The datasets from each experimental group is presented in individual line 
graphs (A–E). The data points are the arithmetic mean values for each cellular bleed and the error bars represent the standard error of the mean 
(SEM). The x axis represents the weeks post inoculation with C. abortus (intranasal inoculation (i/n) Groups 1–3 with i/n sham control Group 4; and 
sub‑cutaneous inoculation (s/c) Group 5). The week numbering for groups 1–4 are consistent in relation to i/n whereas group 5 is in relation to s/c. 
The y axis represents the arithmetic mean IFN‑γ production in picograms/millilitre concentration values. A Group 1 (low dose), B Group 2 (medium 
dose), C Group 3 (high dose), D Group 4 (sham control) and E Group 5 (sub‑cutaneous control). The statistics summarised in the figure been derived 
from Linear Mixed Modelling (LMM) as described in detail in section “Statistical analyses”.
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Analysis of cellular immune correlates with outcome 
of pregnancy
All four of the C. abortus i/n and s/c infection groups 
gave rise to both abortion and lambed outcomes and 
it was important to ascertain if the cellular immune 
responses stimulated by chlamydial antigen correlates 
with infection, disease and/or protection (from abor-
tion). Group 3, the high dose i/n group gave unexpected 
results whereby there were 18 sheep that lambed and 
only one abortion. The results for group 3 are shown in 
Figures 7, 8, 9, 10 for completeness of the datasets but the 
single abortion does not allow us to statistically associ-
ate responses by pregnancy outcome for the group. For 
the ConA responses (cellular proliferation, IFN-γ, IL-4, 
IL-10 and IL-17A production) there were no differences 
in the magnitude of the responses across the five experi-
mental groups. The chlamydial antigen responses yielded 
different results at a whole group level for cellular prolif-
eration, IFN-γ and IL-10 production and this warranted 
closer examination of the associations with pregnancy 
Figure 5 IL‑10 production to C. abortus antigen. Peripheral blood mononuclear cells from the 67 sheep in the five experimental groups were 
purified from whole blood (as described in section “Blood collection and peripheral blood mononuclear cell (PBMC) preparation”) on five occasions 
and set up in lymphocyte stimulation assays in vitro with the UV‑inactivated Chlamydia abortus (C. abortus) antigen (set up as described in section 
“Lymphocyte stimulation assays”). One set of the duplicate plates were harvested for culture supernatants after 96 h and analysed for interleukin 
(IL)‑10 production (as described in section “Cytokine ELISAs”). The datasets from each experimental group are presented in individual line graphs 
(A–E). The data points are the arithmetic mean values for each cellular bleed and the error bars represent the standard error of the mean (SEM). 
The x axis represents the weeks post inoculation with C. abortus (intranasal inoculation (i/n) Groups 1–3 with i/n sham control Group 4; and 
sub‑cutaneous inoculation (s/c) Group 5). The week numbering for groups 1–4 are consistent in relation to i/n whereas group 5 is in relation to s/c. 
The y axis represents the arithmetic mean IL‑10 production in biological units/millilitre amounts. A Group 1 (low dose), B Group 2 (medium dose), 
C Group 3 (high dose), D Group 4 (sham control) and E Group 5 (sub‑cutaneous control). The statistics summarised in the figure been derived from 
Linear Mixed Modelling (LMM) as described in detail in section “Statistical analyses”.
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outcomes for groups 1, 2 and 5 (A full summary of the 
estimates from LMM is provided; Additional file 6).
For cellular proliferation, the specific responses in 
each group 1, 2, 3 and 5  split by outcome largely over-
lap (aborted groups vs lambed groups; Figures  7A, B 
and D). Across the groups (1, 2, 3 and 5), the trend sug-
gests that responses from the lambed groups are gener-
ally higher than those from aborted groups but this is not 
statistically significant (foetus effect, p = 0.0692, group 
3 is not part of this comparison). The responses from 
aborted groups and lambed groups have greater vari-
ability following i/n or s/c C. abortus infection as repre-
sented graphically at the sample point values with larger 
error bars (Figures 7A, B and D from week 6 i/n or week 
5  s/c). Additionally, there are no associations between 
group response and pregnancy outcome (group: foetus, 
p = 0.5162). At the first bleed, post i/n for groups 1 and 2 
and s/c group 5 (week 6 i/n and week 5 s/c, respectively), 
responses in the lambed groups are higher or equal to the 
responses in the aborted groups.
Figure 6 IL‑17A production to C. abortus antigen. Peripheral blood mononuclear cells from the 67 sheep in the five experimental groups 
were purified from whole blood (as described in section “Blood collection and peripheral blood mononuclear cell (PBMC) preparation”) on five 
occasions and set up in lymphocyte stimulation assays in vitro with the UV‑inactivated Chlamydia abortus (C. abortus) antigen (set up as described 
in section “Lymphocyte stimulation assays”). One set of the duplicate plates were harvested for culture supernatants after 96 h and analysed for 
interleukin (IL)‑17A production (as described in section “Cytokine ELISAs”). The datasets from each experimental group are presented in individual 
line graphs (A–E). The data points are the arithmetic mean values for each cellular bleed and the error bars represent the standard error of the mean 
(SEM). The x axis represents the weeks post inoculation with C. abortus (intranasal inoculation (i/n) Groups 1–3 with i/n sham control Group 4; and 
sub‑cutaneous inoculation (s/c) Group 5). The week numbering for groups 1–4 are consistent in relation to i/n whereas group 5 is in relation to s/c. 
The y axis represents the arithmetic mean IL‑17A production in picograms/millilitre amounts. A Group 1 (low dose), B Group 2 (medium dose), C 
Group 3 (high dose), D Group 4 (sham control) and E Group 5 (sub‑cutaneous control). The statistics summarised in the figure been derived from 
Linear Mixed Modelling (LMM) as described in detail in section “Statistical analyses”.
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Figure 7 Cellular proliferation to C. abortus antigen for Groups 1, 2, 3 and 5 separated by pregnancy outcome. Peripheral blood 
mononuclear cells from the 67 sheep in the five experimental groups were purified from whole blood (as described in section “Blood collection 
and peripheral blood mononuclear cell (PBMC) preparation”) on five occasions and set up in lymphocyte stimulation assays in vitro with the 
UV‑inactivated Chlamydia abortus (C. abortus) antigen (set up as described in section “Lymphocyte stimulation assays”). One set of the duplicate 
plates were analysed for cellular proliferation (described in full detail, section “Cell proliferation assays”). In brief, cellular proliferation was measured 
for the last 18 h of the 120 h culture, 0.5 microCurie/well was added and plates were harvested and data collated for individual animals as the 
geometric mean of quadruplicate values. The datasets from experimental group 1 (low dose), group 2 (medium dose), group 3 (high dose) and 
group 5 (sub‑cutaneous control) are presented in graphs (A–D). In each graph the data has separated by outcome of pregnancy into aborted and 
lambed groups (as described in brief in section “Baseline immunological responses for assignment of experimental animal groups” or in full detail in 
Longbottom et al. [11]) represented yellow and black data points respectively. The data points are the arithmetic mean values for each cellular bleed 
and the error bars represent the standard error of the mean (SEM) except for group 3 where there is a single animal in the aborted group. The x axis 
represents the weeks post inoculation with C. abortus (intranasal inoculation (i/n) Groups 1 and 2 with sub‑cutaneous inoculation (s/c) Group 5). 
The week numbering for groups 1, 2 and 3 are consistent in relation to i/n whereas group 5 is in relation to s/c. The y axis represents the arithmetic 
mean cellular proliferation in counts per minute units. (a) Group 1 (low dose), (b) Group 2 (medium dose) and (c) Group 3 (high dose and (d) Group 
5 (sub‑cutaneous control). The statistics summarised in the figure been derived from Linear Mixed Modelling (LMM) exclude analysis of group 3 (*) 
as described in detail in section “Statistical analyses” with a summary of estimates disclosed in Additional file 6).
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Figure 8 IFN‑γ production to C. abortus antigen for Groups 1, 2, 3 and 5 separated by pregnancy outcome. Peripheral blood mononuclear 
cells from the 67 sheep in the five experimental groups were purified from whole blood (as described in section “Blood collection and peripheral 
blood mononuclear cell (PBMC) preparation”) on five occasions and set up in lymphocyte stimulation assays in vitro with the UV‑inactivated 
Chlamydia abortus (C. abortus) antigen (set up as described in section “Lymphocyte stimulation assays”). One set of the duplicate plates were 
harvested for culture supernatants after 96 h and analysed for Interferon‑gamma production (as previously described [8]). The datasets from 
experimental group 1 (low dose), group 2 (medium dose), group 3 (high dose) and group 5 (sub‑cutaneous control) are presented in graphs 
A–D. In each graph the data has separated by outcome of pregnancy into aborted and lambed groups (as described in brief in section “Baseline 
immunological responses for assignment of experimental animal groups” or in full detail in Longbottom et al. [11]) represented yellow and black 
data points respectively. The data points are the arithmetic mean values for each cellular bleed and the error bars represent the standard error of 
the mean (SEM) except for group 3 where there is a single animal in the aborted group. The x axis represents the weeks post inoculation with C. 
abortus (intranasal inoculation (i/n) Groups 1, 2, and 3 with sub‑cutaneous inoculation (s/c) Group 5). The week numbering for groups 1, 2 and 3 
are consistent in relation to i/n whereas group 5 is in relation to s/c. The y axis represents the arithmetic mean IFN‑γ production in pictograms/
millilitre concentration values. A Group 1 (low dose), B Group 2 (medium dose), C Group 3 (high dose) and D Group 5 (sub‑cutaneous control). The 
statistics summarised in the figure been derived from Linear Mixed Modelling (LMM) exclude analysis of group 3 (*) as described in detail in section 
“Statistical analyses” with a summary of estimates disclosed in Additional file 6).
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Figure 9 IL‑10 production to C. abortus antigen for Groups 1, 2, 3 and 5 separated by pregnancy outcome. Peripheral blood mononuclear 
cells from the 67 sheep in the five experimental groups were purified from whole blood (as described in section “Blood collection and peripheral 
blood mononuclear cell (PBMC) preparation”) on five occasions and set up in lymphocyte stimulation assays in vitro with the UV‑inactivated 
Chlamydia abortus (C. abortus) antigen (set up as described in section “Lymphocyte stimulation assays”). One set of the duplicate plates were 
harvested for culture supernatants after 96 h and analysed for interleukin (IL)‑10 (as described in section “Cytokine ELISAs”). The datasets from 
experimental group 1 (low dose), group 2 (medium dose), group 3 (high dose) and group 5 (sub‑cutaneous control) are presented in graphs 
(A–D). In each graph the data has separated by outcome of pregnancy into aborted and lambed groups (as described in brief in section “Baseline 
immunological responses for assignment of experimental animal groups” or in full detail in Longbottom et al. [11]) represented yellow and black 
data points respectively. The data points are the arithmetic mean IL‑10 production values for each cellular bleed and the error bars represent the 
standard error of the mean (SEM) except for group 3 where there is a single animal in the aborted group. The x axis represents the weeks post 
inoculation with C. abortus (intranasal inoculation (i/n) Groups 1, 2 and 3 with sub‑cutaneous inoculation (s/c) Group 5). The week numbering for 
groups 1, 2 and 3 are consistent in relation to i/n whereas group 5 is in relation to s/c. The y axis represents the arithmetic mean IL‑10 production 
in biological units/millilitre values. A Group 1 (low dose), B Group 2 (medium dose), C Group 3 (high dose) and D Group 5 (sub‑cutaneous control). 
The statistics summarised in the figure been derived from Linear Mixed Modelling (LMM) exclude analysis of group 3 (*) as described in detail in 
section “Statistical analyses” with a summary of estimates disclosed in Additional file 6).
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Figure 10 IL‑17A production to C. abortus antigen for Groups 1, 2, 3 and 5 separated by pregnancy outcome. Peripheral blood 
mononuclear cells from the 67 sheep in the five experimental groups were purified from whole blood (as described in section “Blood collection 
and peripheral blood mononuclear cell (PBMC) preparation”) on five occasions and set up in lymphocyte stimulation assays in vitro with the 
UV‑inactivated Chlamydia abortus (C. abortus) antigen (set up as described in section “Lymphocyte stimulation assays”). One set of the duplicate 
plates were harvested for culture supernatants after 96 h and analysed for interleukin (IL)‑17A (as described in section “Cytokine ELISAs”). The 
datasets from experimental group 1 (low dose), group 2 (medium dose), group 3 (high dose) and group 5 (sub‑cutaneous control) are presented 
in graphs (A–D). In each graph the data has separated by outcome of pregnancy into aborted and lambed groups (as described in brief in section 
“Baseline immunological responses for assignment of experimental animal groups” or in full detail in Longbottom et al. [11]) represented yellow and 
black data points respectively. The data points are the arithmetic mean IL‑10 production values for each cellular bleed and the error bars represent 
the standard error of the mean (SEM) except for group 3 where there is a single animal in the aborted group. The x axis represents the weeks post 
inoculation with C. abortus (intranasal inoculation (i/n) Groups 1, 2 and 3 with sub‑cutaneous inoculation (s/c) Group 5). The week numbering for 
groups 1, 2 and 3 are consistent in relation to i/n whereas group 5 is in relation to s/c. The y axis represents the arithmetic mean IL‑17A production 
in picrogram/millilitre values. A Group 1 (low dose), B Group 2 (medium dose), C Group 3 (high dose) and D Group 5 (sub‑cutaneous control). The 
statistics summarised in the figure been derived from Linear Mixed Modelling (LMM) as described in detail in section “Statistical analyses” with a 
summary of estimates disclosed in Additional file 6).
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For IFN-γ production, there is largely overlapping 
responses between aborted and lambed groups across i/n 
low and medium dose groups and the s/c group 5 (Fig-
ures 8A, B and D). The responses between the different 
pregnancy outcomes vary over time. There are no spe-
cific differences between the groups 1, 2 and 5 (group, 
p = 0.1831) and no clear association between IFN-γ and 
outcome of pregnancy (foetus, p = 0.9705). At the first 
bleed post i/n for groups 1 and 2 and s/c group 5 the 
responses in lambed groups is higher than those that 
abort. The responses in group 3 differ, but as noted previ-
ously there is only one animal that aborted here.
For IL-10 production, the aborted and lambed group 
responses again largely overlap (Figures  9A, B and D). 
No clear differences by outcome across the groups 1, 2 
and 5 (group: foetus, p = 0.9189) and no specific con-
sistent pattern of responses associated with abortion or 
lambed groups (foetus, p = 0.3671). In the i/n groups 1 
and 2, the magnitude of responses after infection (week 
0, i/n) for three consecutive bleeds (weeks 6, 17 and 22) 
are consistently higher in aborted groups suggestive of 
an association with abortion outcome. The single animal 
that aborted in group 3 had elevated IL-10 responses 
when compared to the lambed group for three consecu-
tive bleeds (weeks 17, 22 and 36). For completeness, 
the chlamydial antigen-driven IL-17A has also been 
analysed and presented by outcome of pregnancy. As 
observed in Figure 6, there are no distinctive patterns of 
responses emerging based on abortion or lambed out-
come in groups 1, 2 and 5 (Figures 10A, B and D). The 
response is highly variable over time (week, p = 0.0121) 
but there are no clear differences between the same 
groups (Group, p = 0.3970) or pregnancy outcome (Foe-
tus, p = 0.4510).
Discussion
The development of improved methods for the preven-
tion and control of OEA is dependent on the knowledge 
of immune responses in infected sheep and determining 
how these relate to disease and protection. This is com-
plex for a disease such as OEA that involves a latent, 
subclinical phase in non-pregnant sheep and an active 
disease phase of bacterial multiplication in the placenta 
that precedes abortion [7]. The purpose of this study was 
to investigate cellular immune responses in the different 
stages of OEA with a view to identifying immunological 
signatures that correlate with infection, disease and/or 
protection. We focussed on the production of cytokines 
typically associated with the major  CD4+ve  Thelper cell 
subsets (IFN-γ/Th1; IL-4/Th2; IL-17A/Th17; IL-10/Treg) 
and proliferation of PBMC in a model of intranasal infec-
tion of non-pregnant sheep with C. abortus that results 
in abortion in the subsequent pregnancy [11]. This is a 
very powerful model as it allows investigation of immune 
responses during latent chlamydial infection, a phase that 
has been very difficult to reproduce experimentally [11, 
21].
One of the difficulties in the investigation of immune 
correlates in outbred species is animal-to-animal varia-
tion in immune responsiveness, exemplified by the inter-
animal and intra-animal variability in mitogen-driven 
cellular immune responses in sheep in repeat analyses 
over time [12]. We therefore consider it important to 
ensure that experimental groups are balanced on immune 
responsiveness at the outset when comparisons between 
groups are integral to data interpretation. All of the ani-
mals in this study were initially identified as seronegative 
for C. abortus [11], but this does not account for cellular 
immunity. Using antigen-driven and mitogen-stimulated 
PBMC proliferation and IFN-γ production, we excluded 
sheep with a combined profile of the highest background 
responses to chlamydial EBs and lowest responses to 
ConA (Figure 2) and then allocated the sheep to groups 
that were statistically similar for those parameters. Inter-
estingly, further analyses revealed no statistical differ-
ences in the baseline production of IL-4, IL-10 or IL-17A 
in response to antigen or mitogen between the groups 
(Figures 5, 6 and Additional files 3, 4, 5 respectively). This 
gave us further confidence that the groups were well-bal-
anced for the subsequent immunological analyses in rela-
tion to experimental infection.
Infection resulted in an increase in antigen-specific 
cell proliferation, IFN-γ and IL-10 production by PBMC 
(Figures  3, 4, 5), but not IL-4 or IL-17A (Figure  6). The 
levels of IL-4 produced by antigen-stimulated PBMC 
were undetectable for the duration of the experiment, 
hence the data are not shown. The PBMC were capable 
of producing IL-4 as demonstrated by ConA stimula-
tion (Additional file 3) indicating that IL-4 is not a major 
component of the ovine immune response to C. abortus 
irrespective of a mucosal or parenteral route of infection. 
The levels of IL-17A produced by PBMC in response to 
antigen varied across the duration of the experiment, but 
no pattern in relation to infection could be established 
(Figure 6). This is in contrast to production of IFN-γ and 
IL-10 that correlate with infection (Figures 4 and 5), sug-
gesting that different  CD4+ve subsets may be activated by 
C. abortus infection in sheep.
Although PBMC proliferation, IFN-γ and IL-10 pro-
duction correlate with infection, they do not correlate 
with protection. The three doses of intranasal infection 
resulted in different outcomes, with the Group 3 highest 
dose resulting in a very low abortion rate (one ewe) but 
this was not reflected in differences between the groups 
in any of the cellular immunological parameters meas-
ured (Figures  7, 8, 9, 10). This is despite  a strong body 
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of in  vitro evidence showing that IFN-γ is a functional 
correlate of protection, capable of restricting the growth 
of C. abortus [7, 22]. There could be several reasons for 
this. We have used whole chlamydial antigen (UV-killed 
asynchronous mix of elementary bodies and reticulate 
bodies) in our recall assays, hence preferential protective 
cellular responses to antigens that are minor components 
of EBs may not be revealed under such assay conditions. 
Our cytokine assays are also conducted as a “snapshot” 
of the recall response in PBMC supernatants harvested 
96  h after stimulation. We have previously shown that 
the relative expression of antigen-driven IFN-γ and 
IL-10 changes over that time period at both the molec-
ular and protein level [13], so different collection time 
points could reveal different profiles. Such multi-sam-
pling approaches are very difficult to conduct currently, 
but technological developments could make this more 
feasible in the future. We also need to be conscious of 
the fact that we are using PBMC as our immunological 
analyte while we are dealing with a pathogen that has an 
unknown site of latency and causes disease in the sheep 
placenta, where there is evidence of site-specific immune 
modulation [23].
Given the complexities of the disease coupled with the 
immunological parameters that we have been able to 
evaluate, it is extremely difficult to dissect out clear corre-
lates of infection or protection. Taking all of these factors 
into account, systems biology approaches that encompass 
multiple analytes combined with bioinformatics are likely 
to be more informative for identification of immune cor-
relates than single analyte approaches. Diverse technolo-
gies such as PCR, RNAseq, ELISA, multiplexing and flow 
cytometry are now being implemented to characterise 
immune responses for vaccine design [24]. These tech-
nologies are becoming more accessible within the vet-
erinary field [25] and represent future opportunities to 
identify immunological correlates of infection (for diag-
nostics) and protection (for vaccines [26]).
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Additional file 1. Cellular proliferation to ConA. Peripheral blood 
mononuclear cells from the 67 sheep in the five experimental groups 
were purified from whole blood (as described in section “Blood collection 
and peripheral blood mononuclear cell (PBMC) preparation”) on five 
occasions and set up in lymphocyte stimulation assays in vitro with the 
mitogen Concanavalin A (set up as described in section “Lymphocyte 
stimulation assays”). One set of the duplicate plates were analysed for 
cellular proliferation (described in full detail, section “Cell proliferation 
assays”). In brief, cellular proliferation was measured for the last 18 h of the 
120 h culture, 0.5 microCurie/well was added and plates were harvested 
and data collated for individual animals as the geometric mean of quad‑
ruplicate values. The datasets from each experimental group is presented 
in individual line graphs. The data points are the arithmetic mean values 
for each cellular bleed and the error bars represent the standard error of 
the mean (SEM). The x axis represents the weeks post inoculation with 
Chlamydia abortus (intranasal inoculation (i/n) Groups 1–3 with i/n sham 
control Group 4; and sub‑cutaneous inoculation (s/c) Group 5). The week 
numbering for groups 1–4 are consistent in relation to i/n whereas group 
5 is in relation to s/c. The y axis represents the arithmetic mean cellular 
proliferation in counts per minute. (A) Group 1 (low dose), (B) Group 2 
(medium dose), (C) Group 3 (high dose), (D) Group 4 (sham control) and 
(E) Group 5 (sub‑cutaneous control). The statistics summarised in the 
figure been derived from Linear Mixed Modelling (LMM) as described in 
detail in section “Statistical analyses”. 
Additional file 2. IFN‑γ production to ConA. Peripheral blood mono‑
nuclear cells from the 67 sheep in the five experimental groups were 
purified from whole blood (as described in section “Blood collection and 
peripheral blood mononuclear cell (PBMC) preparation”) on five occasions 
and set up in lymphocyte stimulation assays in vitro with the mitogen 
Concanavalin A (set up as described in section “Lymphocyte stimulation 
assays”). One set of the duplicate plates were harvested for culture super‑
natants after 96 h and analysed for Interferon‑gamma (IFN‑γ) production 
(as previously described [11]). The datasets from each experimental group 
is presented in individual line graphs. The data points are the arithmetic 
mean values for each cellular bleed and the error bars represent the 
standard error of the mean (SEM). The x axis represents the weeks post 
inoculation with Chlamydia abortus (intranasal inoculation (i/n) Groups 
1–3 with i/n sham control Group 4; and sub‑cutaneous inoculation (s/c) 
Group 5). The week numbering for groups 1–4 are consistent in relation to 
i/n whereas group 5 is in relation to s/c. The y axis represents the arithme‑
tic mean IFN‑γ production in picograms/millilitre concentration values. (A) 
Group 1 (low dose), (B) Group 2 (medium dose), (C) Group 3 (high dose), 
(D) Group 4 (sham control) and (E) Group 5 (sub‑cutaneous control). The 
statistics summarised in the figure been derived from Linear Mixed Model‑
ling (LMM) as described in detail in section “Statistical analyses”. 
Additional file 3. IL‑4 production to ConA. Peripheral blood mono‑
nuclear cells from the 67 sheep in the five experimental groups were 
purified from whole blood (as described in section “Blood collection and 
peripheral blood mononuclear cell (PBMC) preparation”) on five occasions 
and set up in lymphocyte stimulation assays in vitro with the mitogen 
Concanavalin A (ConA) (set up as described in section “Lymphocyte 
stimulation assays”). One set of the duplicate plates were harvested for 
culture supernatants after 96 h and analysed for interleukin (IL)‑4 produc‑
tion (as described in section “Cytokine ELISAs”). The datasets from each 
experimental group are presented in individual line graphs (A–E). The 
data points are the arithmetic mean values for each cellular bleed and 
the error bars represent the standard error of the mean (SEM). The x axis 
represents the weeks post inoculation with Chlamydia abortus (intranasal 
inoculation (i/n) Groups 1–3 with i/n sham control Group 4; and sub‑
cutaneous inoculation (s/c) Group 5). The week numbering for groups 
1–4 are consistent in relation to i/n whereas group 5 is in relation to s/c. 
The y axis represents the arithmetic mean IL‑4 production in picogram/
millilitre concentrations. (A) Group 1 (low dose), (B) Group 2 (medium 
dose), (C) Group 3 (high dose), (D) Group 4 (sham control) and (E) Group 
5 (sub‑cutaneous control). The statistics summarised in the figure been 
derived from Linear Mixed Modelling (LMM) as described in detail in sec‑
tion “Statistical analyses”. 
Additional file 4. IL‑10 production to ConA. Peripheral blood mono‑
nuclear cells from the 67 sheep in the five experimental groups were 
purified from whole blood (as described in section “Blood collection and 
peripheral blood mononuclear cell (PBMC) preparation”) on five occasions 
and set up in lymphocyte stimulation assays in vitro with the mitogen 
Concanavalin A (ConA) (set up as described in section “Lymphocyte 
stimulation assays”). One set of the duplicate plates were harvested 
for culture supernatants after 96 h and analysed for interleukin (IL)‑10 
production (as described in section “Cytokine ELISAs”). The datasets from 
each experimental group are presented in individual line graphs (A–E). 
The data points are the arithmetic mean values for each cellular bleed and 
the error bars represent the standard error of the mean (SEM). The x axis 
represents the weeks post inoculation with Chlamydia abortus (intra‑
nasal inoculation (i/n) Groups 1–3 with i/n sham control Group 4; and 
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sub‑cutaneous inoculation (s/c) Group 5). The week numbering for groups 
1–4 are consistent in relation to i/n whereas group 5 is in relation to s/c. 
The y axis represents the arithmetic mean IL‑10 production in biological 
units/millilitre amounts. (A) Group 1 (low dose), (B) Group 2 (medium 
dose), (C) Group 3 (high dose), (D) Group 4 (sham control) and (E) Group 
5 (sub‑cutaneous control). The statistics summarised in the figure been 
derived from Linear Mixed Modelling (LMM) as described in detail in sec‑
tion “Statistical analyses”. 
Additional file 5. IL‑17A production to ConA. Peripheral blood mono‑
nuclear cells from the 67 sheep in the five experimental groups were 
purified from whole blood (as described in section “Blood collection and 
peripheral blood mononuclear cell (PBMC) preparation”) on five occasions 
and set up in lymphocyte stimulation assays in vitro with the mitogen 
Concanavalin A (ConA) (set up as described in section “Lymphocyte 
stimulation assays”). One set of the duplicate plates were harvested for 
culture supernatants after 96 h and analysed for interleukin (IL)‑17A 
production (as described in section “Cytokine ELISAs”). The datasets from 
each experimental group are presented in individual line graphs (A–E). 
The data points are the arithmetic mean values for each cellular bleed and 
the error bars represent the standard error of the mean (SEM). The x axis 
represents the weeks post inoculation with Chlamydia abortus (intranasal 
inoculation (i/n) Groups 1–3 with i/n sham control Group 4; and sub‑
cutaneous inoculation (s/c) Group 5). The week numbering for groups 
1–4 are consistent in relation to i/n whereas group 5 is in relation to s/c. 
The y axis represents the arithmetic mean IL‑17A production in picogram/
millilitre concentrations. (A) Group 1 (low dose), (B) Group 2 (medium 
dose), (C) Group 3 (high dose), (D) Group 4 (sham control) and (E) Group 
5 (sub‑cutaneous control). The statistics summarised in the figure been 
derived from Linear Mixed Modelling (LMM) as described in detail in sec‑
tion “Statistical analyses”. 
Additional file 6. Summary of estimates from linear mixed modelling 
of the cellular Chlamydia abortus antigen‑driven cellular prolifera‑
tion, interferon‑gamma production, interleukin (IL)‑10 and IL‑17A 
production in relation to pregnancy outcome. Here are the analysis of 
variance tables from the linear mixed model (LMM) fits relating to each 
immunological parameter graphically represented in the section “Analysis 
of cellular immune correlates with outcome of pregnancy”. The tables refer 
to (A) estimates of the statistical significance of the fixed‑effects terms of 
the models, including week, treatment group, pregnancy outcome (term 
called Foetus: either lambed or aborted) and its potential 2‑level and 
3‑level interactions; and (B) post hoc comparisons between groups for 
each pregnancy outcome from the model fits. Note that the comparisons 
are made between groups 1 (low dose), group 2 (medium dose), and the 
challenge control group 5 (s/c control) only as explained in the section 
“Statistical analyses”.
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